Ainos (NASDAQ:AIMD) Trading Down 0.6% – Here’s What Happened

Shares of Ainos, Inc. (NASDAQ:AIMD) traded down 0.6% during mid-day trading on Tuesday . The stock traded as low as $3.41 and last traded at $3.46. 137,292 shares traded hands during mid-day trading, an increase of 98% from the average session volume of 69,418 shares. The stock had previously closed at $3.48.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of Ainos from a “sell” rating to a “hold” rating in a research report on Friday, September 5th.

Ainos Stock Performance

The stock’s 50-day moving average price is $3.35 and its 200 day moving average price is $2.97. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 0.96. The company has a market cap of $16.12 million, a P/E ratio of -0.69 and a beta of 2.25.

Ainos (NASDAQ:AIMD) last posted its earnings results on Wednesday, August 13th. The company reported ($0.99) earnings per share (EPS) for the quarter.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.